CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

KILITCH DRUGS (INDIA) LTD.

NSE : KILITCHBSE : 524500ISIN CODE : INE729D01010Industry : Pharmaceuticals & DrugsHouse : Private
BSE339.157.7 (+2.32 %)
PREV CLOSE () 331.45
OPEN PRICE () 347.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2031
TODAY'S LOW / HIGH ()335.00 354.60
52 WK LOW / HIGH ()271.3 404.9
NSE336.803.1 (+0.93 %)
PREV CLOSE() 333.70
OPEN PRICE () 345.00
BID PRICE (QTY) 336.80 (985)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 13462
TODAY'S LOW / HIGH() 333.10 356.40
52 WK LOW / HIGH ()299.95 404.95
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1992

Management Info :

- Chairman Mukund P Mehta - Managing Director

Registered Office :

Address : C 301/2 M I D C,T T C Industrial Area,Pawane Village,
Navi Mumbai,
Maharashtra-400705

Phone : 022-62996300

Website : www.kilitch.com

Registrar's Details : MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
04Feb Kilitch Drugs (India) informs about pr
Kilitch Drugs (India) has informed that it enclosed its Press Release re..
22Jan Kilitch Drugs makes additional investm
Kilitch Drugs (India) has made additional investment of $2,00,000 to acq..
22Jan Kilitch Drugs surges on making additio
Kilitch Drugs (India) is currently trading at Rs. 339.20, up by 2.20 poi..
22Oct Kilitch Drugs (India) informs about lo
Kilitch Drugs (India has informed that the Company has received intimati..
21Sep Kilitch Drugs (India) informs about lo
Kilitch Drugs (India) has informed that it enclosed intimation of Issue..
Financials
in Millions
QTR Dec 24 ANNUAL 24
Net Profit68.82175.75
Gross Profit 95.19 233.54
Operating Profit 104.88265.06
Net Sales 465.131315.99
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 30999.30 (4.80%)
M.Cap ( in Cr)
65871.35
Neuland Laboratories (BSE)
 12655.30 (8.12%)
M.Cap ( in Cr)
16236.61
Astrazeneca Pharma I (BSE)
 8871.70 (4.65%)
M.Cap ( in Cr)
22179.25
Divi's Lab (BSE)
 5732.25 (2.49%)
M.Cap ( in Cr)
152173.23
Glaxosmithkline Phar (BSE)
 2876.65 (4.72%)
M.Cap ( in Cr)
48732.19
Shareholding Pattern
PROMOTERS 69.23%
NON-INSTITUTION 30.77%
FI/BANKS/INSURANCE 0%
MUTUAL FUNDS/UTI 0%
GOVERNMENT 0%
FII 0%
Mf Holding
Scheme NameHold(%)
No Data Found

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX76734.891577.63 (2.10%)
NIFTY23328.55500.00 (2.19%)
Dow Jones 40524.79312.08 (0.78%)
Nasdaq 16831.48107.02 (0.64%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI